NKGen Biotech Inc. Gains 121.64%

Wed, Feb 12, 2025 at 07:29 PM

NKGen Biotech Inc. (NKGN:NASDAQ) jumped higher at $0.84, a gain of 121.6%. On Wed, Feb 12, 2025, NKGN:NASDAQ touched a New 2-Week High of $0.84. The stock got featured on our News Catalysts scanner on Wed, Feb 12, 2025 at 10:08 AM in the 'BIOTECH' category. From Thu, Jan 30, 2025, the stock recorded 11.11% Up Days and 40.00% Green Days

The stock spiked on Thu, Dec 26, 2024 at $0.97 with a volume of 1M+.

About NKGen Biotech Inc. (NKGN:NASDAQ)

NKGen Biotech is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat...

Top 10 Gainers:

Athena Technology Acquisition Corp. II Class A (ATEK:NYSE), 400%
Tivic Health Systems Inc. (TIVC:NASDAQ), 197.87%
Mynaric AG (MYNA:NASDAQ), 134.32%
Kindly MD Inc. (KDLY:NASDAQ), 129.37%
Xilio Therapeutics Inc. (XLO:NASDAQ), 125.27%
NKGen Biotech Inc. (NKGN:NASDAQ), 121.64%
Sacks Parente Golf Inc. (SPGC:NASDAQ), 85.17%
Firefly Neuroscience Inc Com (AIFF:NASDAQ), 54.4%
Yoshiharu Global Co. (YOSH:NASDAQ), 52.84%
Genius Group Limited (GNS:NYSEMKT), 48.44%